Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle melanocytes die during hair regression.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Retinoids can change the hair growth cycle by extending the growth phase and shortening the rest phase.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Partially bald areas in Indian AGA patients still have hair growth cells, suggesting early treatment is best.

The model accurately simulates human hair growth and hair loss patterns.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

EGFR helps hair follicles transition properly by controlling Stathmin levels.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Telogen effluvium is a type of hair loss that happens when stress or illness causes many hairs to enter the resting phase and fall out.

Higher DHEA-S levels in hirsute females affect hair growth phases.

New cells join the hair's dermal papilla during the growth phase, possibly affecting hair thickness.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

GasderminA3 is important for normal hair cycle transitions by controlling Wnt signaling.

Hair loss, known as androgenic alopecia, can start in teenage years and may not always be hormone-related. It's important to do extra tests in young cases and remember it can greatly affect a teenager's mental health.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Hair growth and shedding are linked and can be disrupted, causing a delay known as the hair eclipse phenomenon, which is common in certain hair conditions and could lead to new treatments.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Hair shedding that lasts over 6 months may need a closer look, but often just reassurance is enough.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

Hair follicles can regenerate after radiation damage but not during a specific growth phase.

Apoptosis in hair follicles varies by growth phase, with TGF-β possibly starting the catagen phase.

PDGF isoforms can promote and sustain hair growth.

Loose Anagen Syndrome is a hair condition where hairs can be easily pulled out, mainly affecting young girls, and may improve on its own or with treatment.

Estetrol helps keep scalp hair in the growth phase longer and improves hair follicle health by affecting the hair root and increasing stem cells.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Loose anagen hair syndrome causes easily pulled, thin hair in kids but is harmless and temporary.

Loose Anagen Hair syndrome occurs in dark-skinned children and often improves on its own.

Some hair growth cells remain in partially bald areas of Indian men with hair loss.